echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > APL Bioeng: use CRISPR to clean roads and eliminate diseases

    APL Bioeng: use CRISPR to clean roads and eliminate diseases

    • Last Update: 2020-02-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    A protein editing cofactor is clearing the way for cutting and pasting DNA editors, such as CRISPR, to access previously inaccessible genes of interest Opening these regions of the genetic code is essential to improve CRISPR's efficiency and move towards future gene based disease treatment The DNA binding editing aids were designed by an American who described their design in APL bioengineering Karmella Haynes, a leading author from Arizona State University and Emory University, said: "the innovation of this paper is that another protein that is transferred with simultaneous interpreting of CRISPR DNA editor is used to remove chromatin packaging, so that CRISPR can get DNA more easily " DNA usually does not exist in cells in the form of freely obtained double helix structure It's surrounded by a protective substance called chromatin, which controls which genes the cell activates or silences at any time Unfortunately, the packaging prevents scientists who are trying to contact DNA from correcting the pathogenic mutation In CRISPR's discussion, Haynes described chromatin blocking as "the elephant in the room," but it wasn't until 2016 that Haynes's team conducted some clever experiments to capture this effect that it directly proved this Her team is trying to solve this problem by studying different methods of chromatin destruction They use a sophisticated artificial system that turns on or off the chromatin packaging of a gene, the luciferase gene, which encodes an easily detected luminescent protein In detecting the chromatin filling state, the team found several editing assistants, called DNA binding transient expression activation associated proteins (AAPS), which destroyed chromatin and enabled CRISPR to successfully edit luciferase genes "Our idea is that if CRISPR needs to be bound to a gene to work, but it can't be bound to a mutated gene for editing, then you can send in our proteins that can turn on chromatin, rearrange chromatin, and make it easier for genes to CRISPR edit genes," Haynes explained, hoping that others will use their system to improve CRISPR efficiency She points out that AAPS can be adjusted for different genes by changing the DNA binding region "It is interesting to find out whether one AAP is more effective than others in destroying the chromatin of some genes Or whether binding proteins together would further enhance CRISPR's editing power, "Haynes said "I envision a set of CRISPR cofactors that can be used to enhance CRISPR activities " reference material: Karmella A Haynes Site-directed targeting of transcriptional activation-associated proteins to repressed chromatin restores CRISPR activity APL Bioengineering, 2020; 4 (1): 016102 DOI: 10.1063/1.5127302
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.